Biotech industry boosted by billions in investment
The biotechnology industry is solidifying as a stable,
steady financial investment field marked by more than
a decade of growth, according to industry experts.
Coupled with dozens of new product deliveries in 2005,
biotechnology industry executives say investors are recognizing
the laboratory largess in the field.
“Investors have recognized the industry’s
value, and in the last six years as the industry has
matured, biotech and biopharmaceutical firms have raised
more than $120 billion in financing, the majority of
which is used for the purposes of research and development,” said
Jim Greenwood, president and CEO of the Biotechnology
Industry Organization.
“Ongoing favorable investor response has fueled
the industry’s innovative technology that has moved
an idea or vision from the laboratory to the market,” he
said.
According to BIO, biotech firms raised roughly $20.1
billion in public and private financing in 2005 and succeeded
in securing FDA approval on 38 new biotech and biotech-related
products, expanded labels and other therapies.
Along with a financial investment boast from the private
sector, the industry will see significant growth thanks
to nearly $1 billion in funding for bioenergy products
and R&D through the Energy Policy Act, signed by
President Bush in August.
“The act will encourage the production of domestic
sources of energy and reduce America's dependence on
foreign oil,” Greenwood said.
RSI - Executive Search Firm News | Executive & Candidate
Resources for the Executive Search Recruiting Industry
Current Location: Executive Search Firm Industry Articles - Biotech Investment Boosted
Search Solutions
RSI's Executive Search
Process will find the best Candidate for your position.
RSI's Executive Recruiting
Experts bring Employers only the best Executive talent.